Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Change in Receivables (2024 - 2026)

Geron's (GERN) quarterly Change in Receivables came in at $8.9 million in Q2 2026, up 67.6% year-over-year from $5.3 million in Q2 2025, and up 82.63% quarter-over-quarter from $4.9 million in Q1 2026.

Analysis

Geron (GERN) Change in Receivables (2024 - 2026) Analysis & Trends

Geron has disclosed Change in Receivables across 3 years of filings, most recently posting $8.9 million for Q2 2026.

  • In Q2 2026, Change in Receivables rose 67.6% year-over-year to $8.9 million; the TTM figure through Jun 2026 stood at $14.1 million (down 60.18% YoY), while the FY2025 annual figure was $991000.0, down 97.22% from the prior year.
  • Change in Receivables came in at $8.9 million for Q2 2026 at Geron, up from $4.9 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $27.1 million in Q3 2024 to a low of -$4.6 million in Q1 2025.
  • Average Change in Receivables over 3 years is $5.6 million, with a median of $4.9 million recorded in 2026.
  • The largest YoY upside for Change in Receivables was 510.18% in 2025 against a maximum downside of 104.69% in 2025.
  • Over 3 years, Change in Receivables stood at $7.7 million in 2024, then slumped by 79.45% to $1.6 million in 2025, then jumped by 465.7% to $8.9 million in 2026.
  • Per Business Quant data, the three most recent Change in Receivables figures were $8.9 million in Q2 2026, $4.9 million in Q1 2026, and $1.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 1.09 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 333.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 140.20 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 838.50 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -53.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 31.60 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 269.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Geron 914.60 Mn 613.75 Mn - 8.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.94 Mn
Mar 31, 2026 4.89 Mn
Dec 31, 2025 1.58 Mn
Sep 30, 2025 -1.27 Mn
Jun 30, 2025 5.33 Mn
Mar 31, 2025 -4.65 Mn
Dec 31, 2024 7.69 Mn
Sep 30, 2024 27.13 Mn
Jun 30, 2024 874,000.00